Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease
NCT ID: NCT02445547
Last Updated: 2017-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
82 participants
INTERVENTIONAL
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease
NCT05262829
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
NCT04519671
Crohn's Disease Stem Cell Transplantation
NCT00271947
Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease
NCT01874015
The Efficiency of MSC in Refractory Crohn's Disease
NCT02532738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UC-MSCs
UC-MSCs by peripheral intravenous infusion
UC-MSCs by peripheral intravenous infusion
control
received hormone maintenance therapy
received hormone maintenance therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UC-MSCs by peripheral intravenous infusion
received hormone maintenance therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* moderate to severe Crohn's disease (Crohn's disease activity index (CDAI) between 220 and 450)
* had received hormone maintenance therapy for more than 6 months
Exclusion Criteria
* malignancy
* HIV
* syphilis
* hepatitis B
* hepatitis C
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaanxi Provincial People's Hospital
OTHER
Fuzhou General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaanxi Provincial People's Hospital
XI Ail, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCMSC-CD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.